Bracco Japan Appoints Kohei Endo as New President and Representative Director

Bracco Japan Co., Ltd. announced the appointment of Kohei Endo as President and Representative Director, effective March 31, 2026. Kohei Endo began his career as a marketing consultant supporting healthcare companies, earned an MBA from Duke University, and has experience in business reconstruction at a medical device manufacturer and as Japan Branch Manager and head of Hong Kong, Taiwan, and Mongolia regions at Integra LifeSciences. Former President and Representative Director Tetsuaki Sakamoto retired from the board on March 31, 2026. Under the new president, Bracco Japan aims to achieve "early detection of diseases through diagnostic imaging" by introducing new products and innovations to Japan. Bracco Japan Co., Ltd. is the Japanese subsidiary of Bracco Imaging Holding B.V. (Italy), a member of the Bracco Group, and manufactures and sells high-quality pharmaceuticals for diagnostic imaging. Bracco Group, founded in 1927 and headquartered in Milan, Italy, is a multinational conglomerate. It operates in the healthcare sector through Bracco Imaging, Bracco Medical Technologies, and Centro Diagnostico Italiano. The group has approximately 4,000 employees, operates in over 100 countries worldwide, and has an annual consolidated revenue exceeding 2 billion euros.